Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties

被引:0
作者
Torkashvand, Fatemeh [1 ]
Mehranfar, Mahsa [1 ]
Gero, Mahsa Rashidi [1 ,2 ]
Jafarian, Parisa [1 ,3 ]
Mirabzadeh, Esmat [1 ]
Azarian, Bahareh [1 ]
Sardari, Soroush [1 ]
Vaziri, Behrouz [1 ,4 ]
机构
[1] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran
[2] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[3] Islamic Azad Univ, Fac Biol Sci, Dept Biochem, North Tehra branch, Tehran, Iran
[4] Pasteur Inst Iran, Biotechnol Res Ctr, 69,Pasteur St, Tehran 1316943551, Iran
关键词
Monoclonal antibodies; Pharmacokinetics; Trastuzumab; MONOCLONAL-ANTIBODIES; IN-VITRO; HETEROGENEITY; RECOMBINANT; BINDING; IDENTIFICATION; DEAMIDATION;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Post-translational modifications in bioprocessing and storage of recombinant mAbs are the main sources of charge variants. While the profile of these kinds of variants is considered an important quality attribute of therapeutic mAbs, there is controversy about their direct role on safety and efficacy. In this study, the physicochemical and PK properties of separated charge variants belonging to a trastuzumab potential biosimilar were examined.Methods: The APs, BPs, and main variants of trastuzumab were separated and enriched by semi-preparative WCX. A panel of analytical techniques was utilized to characterize the physicochemical properties of these variants. The binding affinity to HER2 and Fc gamma Rs and the PK parameters were evaluated for each variant.Results: Based on the results, the charge variants of the proposed biosimilar had no significant influence on the examined efficacy and PK parameters.Conclusion: During the development and production of biosimilar mAbs, studying the effects of their charge variants on efficacy and PK parameters is needed. DOI: 10.52547/ibj.3837
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
[41]   A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients [J].
Zhou, Xinna ;
Yu, Jing ;
Wang, Wenmiao ;
Song, Guohong ;
Wang, Xiaoli ;
Ren, Jun ;
Di, Lijun ;
Wang, Xinghe .
SPRINGERPLUS, 2015, 4 :1-6
[42]   Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties [J].
Luo, Cheng ;
Chen, Song ;
Xu, Na ;
Wang, Chi ;
Sai, Wen Bo ;
Zhao, Wei ;
Li, Ying Chun ;
Hu, Xiao Jing ;
Tian, Hong ;
Gao, Xiang Dong ;
Yao, Wen Bing .
SCIENTIFIC REPORTS, 2017, 7
[43]   Isolation and Characterization of Monoclonal Antibody Charge Variants by Free Flow Isoelectric Focusing [J].
Hosken, Brian D. ;
Li, Charlene ;
Mullappally, Berny ;
Co, Carl ;
Zhang, Boyan .
ANALYTICAL CHEMISTRY, 2016, 88 (11) :5662-5669
[44]   Simulation of Physicochemical and Pharmacokinetic Properties of Vitamin D3and Its Natural Derivatives [J].
Deb, Subrata ;
Reeves, Anthony Allen ;
Lafortune, Suki .
PHARMACEUTICALS, 2020, 13 (08) :1-16
[45]   Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody [J].
Falck, David ;
Thomann, Marco ;
Lechmann, Martin ;
Koeleman, Carolien A. M. ;
Malik, Sebastian ;
Jany, Cordula ;
Wuhrer, Manfred ;
Reusch, Dietmar .
MABS, 2021, 13 (01)
[46]   Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties [J].
Jihoon Yun ;
Jihyun Kim ;
Jihyun Chung ;
Su-Jeong Hwang ;
Su Jin Park .
Advances in Therapy, 2019, 36 :1700-1714
[47]   Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties [J].
Yun, Jihoon ;
Kim, Jihyun ;
Chung, Jihyun ;
Hwang, Su-Jeong ;
Park, Su Jin .
ADVANCES IN THERAPY, 2019, 36 (07) :1700-1714
[48]   Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis [J].
Rodriguez-Fernandez, Karine ;
Mangas-Sanjuan, Victor ;
Merino-Sanjuan, Matilde ;
Martorell-Calatayud, Antonio ;
Mateu-Puchades, Almudena ;
Climente-Marti, Monica ;
Gras-Colomer, Elena .
PHARMACEUTICS, 2022, 14 (03)
[49]   Pharmacokinetic properties of IgG and various Fc fusion proteins in mice [J].
Unverdorben, Felix ;
Richter, Fabian ;
Hutt, Meike ;
Seifert, Oliver ;
Malinge, Pauline ;
Fischer, Nicolas ;
Kontermann, Roland E. .
MABS, 2016, 8 (01) :120-128
[50]   Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation [J].
Rui, Tian-Qi ;
Zhang, Liang ;
Qiao, Hong-Zhi ;
Huang, Ping ;
Qian, Shuai ;
Li, Jun-Song ;
Chen, Zhi-Peng ;
Fu, Ting-Ming ;
Di, Liu-Qing ;
Cai, Baochang .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (01) :242-249